1. Home
  2. BSRR vs IMMP Comparison

BSRR vs IMMP Comparison

Compare BSRR & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sierra Bancorp

BSRR

Sierra Bancorp

HOLD

Current Price

$35.96

Market Cap

479.7M

Sector

Finance

ML Signal

HOLD

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$0.60

Market Cap

58.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSRR
IMMP
Founded
1977
1987
Country
United States
Australia
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
479.7M
58.2M
IPO Year
2001
2012

Fundamental Metrics

Financial Performance
Metric
BSRR
IMMP
Price
$35.96
$0.60
Analyst Decision
Buy
Hold
Analyst Count
3
3
Target Price
$37.00
$5.50
AVG Volume (30 Days)
30.7K
19.6M
Earning Date
04-20-2026
04-23-2026
Dividend Yield
2.90%
N/A
EPS Growth
10.28
N/A
EPS
3.11
N/A
Revenue
N/A
N/A
Revenue This Year
$11.74
$417.85
Revenue Next Year
$3.63
N/A
P/E Ratio
$11.52
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.06
$0.29
52 Week High
$38.60
$3.53

Technical Indicators

Market Signals
Indicator
BSRR
IMMP
Relative Strength Index (RSI) 61.84 40.41
Support Level $32.93 N/A
Resistance Level $36.75 $1.75
Average True Range (ATR) 0.76 0.07
MACD 0.27 0.11
Stochastic Oscillator 80.88 43.69

Price Performance

Historical Comparison
BSRR
IMMP

About BSRR Sierra Bancorp

Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.

About IMMP Immutep Limited

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: